Usefulness of Circulating Decoy Receptor 3 in Predicting Coronary Artery Disease Severity and Future Major Adverse Cardiovascular Events in Patients with Multivessel Coronary Artery Disease

American Journal of Cardiology

Volumn 116, Issue 7, 2015, Pages 1028-1033

  Chang, Ting Yung ^a,b   Hsu, Chien Yi ^a,b   Huang, Po Hsun ^a,b   Chiang, Chia Hung ^b   Leu, Hsin Bang ^a,b   Huang, Chin Chou ^a,b   Chen, Jaw Wen ^a,b   Lin, Shing Jong ^a,b,c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DECOY RECEPTOR 3; BIOLOGICAL MARKER;

AGED; ANGIOCARDIOGRAPHY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; SYNTAX SCORE; BLOOD; EPIDEMIOLOGY; MORTALITY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TAIWAN; TRENDS;

AGED; BIOMARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TAIWAN;

EID: 84941172049     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.06.041     Document Type: Article

References (30)

1. W.W. Lin, and S.L. Hsieh Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer Biochem Pharmacol 81 2011 838 847
2. D.M. Schrijvers, G.R. De Meyer, M.M. Kockx, A.G. Herman, and W. Martinet Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis Arterioscler Thromb Vasc Biol 25 2005 1256 1261
3. L.Q. Yan, L.J. Guo, F.C. Zhang, and W. Gao The relationship between kidney function and angiographically-derived SYNTAX score Can J Cardiol 27 2011 768 772
4. M.C. Morice, P.W. Serruys, A.P. Kappetein, T.E. Feldman, E. Stahle, A. Colombo, M.J. Mack, D.R. Holmes, J.W. Choi, W. Ruzyllo, G. Religa, J. Huang, K. Roy, K.D. Dawkins, and F. Mohr Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery trial Circulation 129 2014 2388 2394
5. S.C. Hung, T.W. Hsu, Y.P. Lin, and D.C. Tarng Decoy receptor 3, a novel inflammatory marker, and mortality in hemodialysis patients Clin J Am Soc Nephrol 7 2012 1257 1265
6. R.M. Pitti, S.A. Marsters, and D.A. Lawrence Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer Nature 396 1998 699 703
7. K.Y. Yu, B. Kwon, J. Ni, Y. Zhai, R. Ebner, and B.S. Kwon A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis J Biol Chem 274 1999 13733 13736
8. T.S. Migone, J. Zhang, and X. Luo TL1A is a TNF like ligand for DR3 and TR6-DcR3 and functions as a T cell costimulator Immunity 16 2002 479 492
9. S. Macher-Goeppinger, S. Aulmann, N. Wagener, B. Funke, K.E. Tagscherer, A. Haferkamp, M. Hohenfellner, S. Kim, F. Autschbach, P. Schirmacher, and W. Roth Decoy receptor 3 is a prognostic factor in renal cell cancer Neoplasia 10 2008 1049 1056
10. H.F. Tu, C.J. Liu, S.Y. Liu, Y.P. Chen, E.H. Yu, S.C. Lin, and K.W. Chang Serum decoy receptor 3 level: a predictive marker for nodal metastasis and survival among oral cavity cancer patients Head Neck 33 2011 396 402
11. C.R. Yang, S.L. Hsieh, F.M. Ho, and W.W. Lin Decoy receptor 3 increases monocyte adhesion to endothelial cells via NF-b-dependent up-regulation of intercellular adhesion molecule-1, VCAM-1, and IL-8 expression J Immunol 174 2005 1647 1656
12. G. Bamias, G. Kaltsa, S.I. Siakavellas, K. Papaxoinis, E. Zampeli, S. Michopoulos, I. Zouboulis-Vafiadis, and S.D. Ladas High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis Clin Immunol 137 2010 242 249
13. B. Han, R. Bojalil, L.M. Amezcua-Guerra, R. Springall, H. Valderrama-Carvajal, J. Wu, and H. Luo DcR3 as a diagnostic parameter and risk factor for systemic lupus erythematosus Int Immunol 20 2008 1067 1075
14. G. Bamias, S.I. Siakavellas, K.S. Stamatelopoulos, E. Chryssochoou, C. Papamichael, and P.P. Sfikakis Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis Clin Immunol 129 2008 249 255
15. D. Yamada, Y. Asano, T. Takahashi, Y. Masui, N. Aozasa, K. Akamata, S. Noda, Z. Tamaki, Y. Tada, M. Sugaya, S. Sato, and T. Kadono Clinical significance of serum decoy receptor 3 levels in patients with systemic sclerosis Eur J Dermatol 22 2012 351 357
16. Y.Q. Hou, P. Xu, M. Zhang, D. Han, L. Peng, D.Y. Liang, S. Yang, Z. Zhang, J. Hong, X.L. Lou, L. Zhang, and S. Kim Serum decoy receptor 3, a potential new biomarker for sepsis Clin Chim Acta 413 2012 744 748
17. C.Y. Chen, K.Y. Yang, M.Y. Chen, H.Y. Chen, M.T. Lin, Y.C. Lee, R.P. Perng, S.L. Hsieh, P.C. Yang, and T.Y. Chou Decoy receptor 3 levels in peripheral blood predict outcomes of acute respiratory distress syndrome Am J Respir Crit Care Med 180 2009 751 760
18. G. Bamias, K. Stamatelopoulos, E. Zampeli, A. Protogerou, F. Sigala, C. Papamichael, P. Christopoulos, G.D. Kitas, and P.P. Sfikakis Circulating levels of TNF-like cytokine 1A correlate with the progression of atheromatous lesions in patients with rheumatoid arthritis Clin Immunol 147 2013 144 150
19. P.F. Fong Elucidation of signaling pathways involving in interleukin-6 (IL-6) induced decoy receptor 3 (DcR3) expression in a colorectal cancer cell line [Master's Thesis] 2009 National Yang-Ming University Taipei
20. S. Okazaki, M. Sakaguchi, K. Miwa, S. Furukado, H. Yamagami, Y. Yagita, H. Mochizuki, and K. Kitagawa Association of Interleukin-6 with the progression of carotid atherosclerosis: a 9-year follow-up study Stroke 45 2014 2924 2929
21. A.E. Rodriguez, A.O. Maree, J. Mieres, D. Berrocal, L. Grinfeld, C. Fernandez-Pereira, V. Curotto, A. Rodriguez-Granillo, W. O'Neill, and I.F. Palacios Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry Eur Heart J 28 2007 2118 2125
22. A. Kapur, R.J. Hall, I.S. Malik, A.C. Qureshi, J. Butts, M. de Belder, A. Baumbach, G. Angelini, A. de Belder, K.G. Oldroyd, M. Flather, M. Roughton, P. Nihoyannopoulos, J.P. Bagger, K. Morgan, and K.J. Beatt Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial J Am Coll Cardiol 55 2010 432 440
23. M.E. Farkouh, M. Domanski, L.A. Sleeper, F.S. Siami, G. Dangas, M. Mack, M. Yang, D.J. Cohen, Y. Rosenberg, S.D. Solomon, A.S. Desai, B.J. Gersh, E.A. Magnuson, A. Lansky, R. Boineau, J. Weinberger, K. Ramanathan, J.E. Sousa, J. Rankin, B. Bhargava, J. Buse, W. Hueb, C.R. Smith, V. Muratov, S. Bansilal, S. King III, M. Bertrand, V. Fuster FREEDOM Trial Investigators Strategies for multivessel revascularization in patients with diabetes N Engl J Med 367 2012 2375 2384
24. D.N. Feldman, C.L. Gade, A.J. Slotwiner, M. Parikh, G. Bergman, S.C. Wong, R.M. Minutello New York State Angioplasty Registry Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry) Am J Cardiol 98 2006 1334 1339
25. F.G. Hage, R. Venkataraman, G.J. Zoghbi, G.J. Perry, A.M. DeMattos, and A.E. Iskandrian The scope of coronary heart disease in patients with chronic kidney disease J Am Coll Cardiol 53 2009 2129 2140
26. Y.C. Chang, T.L. Hsu, and H.H. Lin Modulatory effects of decoy receptor 3 on T cell and macrophage differentiation and activation J Leukoc Biol 75 2004 486 494
27. M.M. Kockx, and A.G. Herman Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc Res 45 2000 736 746
28. V. Toschi, R. Gallo, M. Lettino, J.T. Fallon, S.D. Gertz, A. Fernandez-Ortiz, J.H. Chesebro, L. Badimon, Y. Nemerson, V. Fuster, and J.J. Badimon Tissue factor modulates the thrombogenicity of human atherosclerotic plaques Circulation 95 1997 594 599
29. I. Tabas Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency Arterioscler Thromb Vasc Biol 25 2005 2255 2264
30. J. Chen, L. Zhang, and S. Kim Quantification and detection of DcR3, a decoy receptor in TNFR family J Immunol Methods 285 2004 63 70